None
Quote | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Last: | $1.075 |
---|---|
Change Percent: | -1.38% |
Open: | $1.07 |
Close: | $1.09 |
High: | $1.1 |
Low: | $1.03 |
Volume: | 515,889 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire Invited to Present Updated Endometrial Cancer Data During Special Session "ASCO Plenary Series: Rapid Abstract Updates" ...
2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
Message Board Posts | Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Subject | By | Source | When |
---|---|---|---|
Cara, Iovance, and Karyopharm among biotechs with no | dcaf7 | investorshub | 03/11/2023 2:28:46 PM |
Good news for Karyopharm. | dcaf7 | investorshub | 03/05/2023 3:00:58 PM |
znewcar1: Not a lot of Views an hour into it. $KPTI | znewcar1 | investorshangout | 11/04/2022 2:41:51 PM |
znewcar1: $KPTI 13% $5.1 HOD5.54 LOD4.33 what a Vee huge sel vol | znewcar1 | investorshangout | 11/04/2022 2:41:02 PM |
znewcar1: KPTI 19% v17,7M c14.38 f75,7M H14.73 morning pop >13 held14 | znewcar1 | investorshangout | 02/18/2022 10:07:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
NASDAQ Market:
Karyopharm Therapeutics Inc. Website:
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire Invited to Present Updated Endometrial Cancer Data During Special Session "ASCO Plenary Series: Rapid Abstract Updates" ...
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences PR Newswire NEWTON, Mass. , March 6, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company ...
2024-02-29 18:15:15 ET Image source: The Motley Fool. Karyopharm Therapeutics (NASDAQ: KPTI) Q4 2023 Earnings Call Feb 29, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Karyopharm Therapeutics (KPTI) Q4 2023 Earnings C...